Literature DB >> 16000316

CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study.

Xingguang Luo1, Henry R Kranzler, Lingjun Zuo, Shuang Wang, Hilary P Blumberg, Joel Gelernter.   

Abstract

Cholinergic muscarinic 2 receptor (CHRM2) is implicated in memory and cognition, functions impaired in many neuropsychiatric disorders. Wang et al. [Wang, J.C., Hinrichs, A.L., Stock, H., Budde, J., Allen, R., Bertelsen, S., Kwon, J.M., Wu, W., Dick, D.M., Rice, J. et al. (2004) Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum. Mol. Genet., 13, 1903-1911] reported that variation in CHRM2 gene predisposed to alcohol dependence (AD) and major depressive syndrome. We examined the relationships between variation in CHRM2 and AD, drug dependence (DD) and affective disorders, using a novel extended case-control structured association (SA) method. Six markers at CHRM2 and 38 ancestry-informative markers (AIMs) were genotyped in a sample of 871 subjects, including 333 healthy controls [287 European-Americans (EAs) and 46 African-Americans (AAs)] and 538 AD and/or DD subjects (415 with AD and 346 with DD and 382 EAs and 156 AAs). The same CHRM2 markers were genotyped in a sample of 137 EA subjects with affective disorders. All of the six markers were in Hardy-Weinberg equilibrium in controls, but SNP3 (rs1824024) was in Hardy-Weinberg disequilibrium in the AD and DD groups. Using conventional case-control comparisons, some markers were nominally significantly or suggestively associated with phenotypes before or after controlling for population stratification and admixture effects, but these associations were not significant after multiple test correction. However, regression analysis identified specific alleles, genotypes, haplotypes and diplotypes that were significantly associated with risk for each disorder. We conclude that variation in CHRM2 predisposes to AD, DD and affective disorders. One haplotype block within the 5'-UTR of CHRM2 may be more important for the development of these disorders than other regions. Interaction between two specific alleles within this block and interaction between two specific diplotypes covering this block multiplicatively increased risk for AD and DD. Although interaction between these two diplotypes also increased risk for affective disorders, the magnitude of the increased risk was less than the sum of the individual risks. In addition, a specific diplotype might inversely affect risk for AD and DD and risk for affective disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000316     DOI: 10.1093/hmg/ddi244

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  94 in total

1.  Genomewide linkage scan for opioid dependence and related traits.

Authors:  Joel Gelernter; Carolien Panhuysen; Marsha Wilcox; Victor Hesselbrock; Bruce Rounsaville; James Poling; Roger Weiss; Susan Sonne; Hongyu Zhao; Lindsay Farrer; Henry R Kranzler
Journal:  Am J Hum Genet       Date:  2006-03-16       Impact factor: 11.025

2.  Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence.

Authors:  Xingguang Luo; Henry R Kranzler; Lingjun Zuo; Shuang Wang; Nicholas J Schork; Joel Gelernter
Journal:  Am J Hum Genet       Date:  2006-04-11       Impact factor: 11.025

3.  Personality traits of agreeableness and extraversion are associated with ADH4 variation.

Authors:  Xingguang Luo; Henry R Kranzler; Lingjun Zuo; Shuang Wang; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2006-10-25       Impact factor: 13.382

4.  Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence.

Authors:  Christian S Hendershot; Angela D Bryan; Sarah W Feldstein Ewing; Eric D Claus; Kent E Hutchison
Journal:  J Abnorm Child Psychol       Date:  2011-07

5.  Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies.

Authors:  Gary A Heiman; Elizabeth Ogburn; Prakash Gorroochurn; Katherine M Keyes; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2007-10-22       Impact factor: 4.492

6.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

7.  GRM8 genotype is associated with externalizing disorders and greater inter-trial variability in brain activation during a response inhibition task.

Authors:  Lance O Bauer; Jonathan M Covault
Journal:  Clin Neurophysiol       Date:  2020-04-02       Impact factor: 3.708

8.  Reward processing deficits and impulsivity in high-risk offspring of alcoholics: A study of event-related potentials during a monetary gambling task.

Authors:  Chella Kamarajan; Ashwini K Pandey; David B Chorlian; Niklas Manz; Arthur T Stimus; Lance O Bauer; Victor M Hesselbrock; Marc A Schuckit; Samuel Kuperman; John Kramer; Bernice Porjesz
Journal:  Int J Psychophysiol       Date:  2015-09-18       Impact factor: 2.997

9.  CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.

Authors:  Silvia Jiménez-Morales; Juan Luis Jiménez-Ruíz; Blanca Estela Del Río-Navarro; Efraín Navarro-Olivos; Guillermo Escamilla-Guerrero; Ram Savan; Michael Dean; Lorena Orozco
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

Review 10.  Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment.

Authors:  Christian Jacob
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.